Labsinlove

PEOPLE FIRST

Our R&D is cofunded by the agency Andalucía Trade with EU funds (grant 4IIDE2400014) and the national Agencia Estatal de Investigación (Ministerio de Ciencia, Innovación y Universidades, grants PTQ2023-013166, DIN2024-013389 and PTQ2025-014556)

Boron compounds for BNCT

HELPING BNCT DEVELOPMENT

We offer a BPA (boronphenylalanine)-based drug to support clinical trials and treatments in Boron Neutron Capture Therapy (BNCT), providing new hope for patients with difficult-to-treat cancers.

Research on new compounds

BORON CONJUGATES

We conduct preclinical research on new selective drugs for BNCT that offer a higher boron load than BPA

Neutron radiobiology studies

CHARACTERIZING NEUTRON BEAMS

We have extensive experience studying the biological effects of thermal, epithermal, and fast neutron beams on both tumour and normal cells .

Serving to BNCT community

COLLABORATIONS

We offer our expertise to the BNCT community through scientific collaborations and strategic alliances .

Labsinlove, S.L. is a health-focused, technology-based company., spin off company from the University of Granada and the Spanish National Research Council (CSIC).